Form 4 for DERM Journey Medical Corp
Accepted 2023-09-08 00:00:00 ET · period of report 2023-09-06 · accession 0001104659-23-099230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-08 | 2023-09-06 | DERM | Maraoui Claude | Pres, CEO, Dir | P - Purchase | $2.52 | +26.0K | 2.15M | +1% | +$65.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2023-09-06 | P | A | 26,044 | $2.52 | 2,153,430 | D | — | — | (F1) Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 6, 2023, was $2.11 to $2.60. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) Includes restricted stock units, which vest over various time periods. |